Clofedanol Hydrochloride

Basic Information

Item Value
DrugBank ID DB04837
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 23

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 nasal cavity disease KG + DL
2 acute laryngopharyngitis KG + DL
3 allergic urticaria KG + DL
4 papillary conjunctivitis KG + DL
5 cold urticaria KG + DL
6 faucial diphtheria KG + DL
7 cervical disc degenerative disorder KG + DL
8 recalcitrant atopic dermatitis KG + DL
9 bronchial disease KG + DL
10 endobronchial leiomyoma KG + DL
11 IgE responsiveness, atopic KG + DL
12 endobronchial lipoma KG + DL
13 bronchus adenoma KG + DL
14 atopic conjunctivitis KG + DL
15 trigeminal autonomic cephalalgia KG + DL
16 headache disorder KG + DL
17 tracheal disease KG + DL
18 massive neonatal aspiration syndrome KG + DL
19 respiratory syncytial virus bronchiolitis KG + DL
20 rosacea conjunctivitis KG + DL
21 hantavirus infectious disease KG + DL
22 meconium aspiration syndrome KG + DL
23 respiratory malformation KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.